Safety and Immunogenicity of a Live-attenuated Vaccine Against Respiratory Syncytial Virus in Elderly Volunteers
Clinical trial NCT04295070 · COMPLETED
Trial details
- NCT number
- NCT04295070
- Sponsor
- Codagenix, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-10
- Primary completion
- 2021-03-06
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.